[1]
|
Marth, T., Moos, V., Müller, C., et al. (2016) Tropheryma whipplei Infection and Whipple’s Disease. The Lancet Infectious Diseases, 16, E13-E22. https://doi.org/10.1016/S1473-3099(15)00537-X
|
[2]
|
Ruggiero, E., Zurlo, A., Giantin, V., et al. (2016) Short Article: Relapsing Whipple’s Disease: A Case Report and Literature Review. European Journal of Gastroenterology & Hepatology, 28, 267-270. https://doi.org/10.1097/MEG.0000000000000539
|
[3]
|
El-Abassi, R., Soliman, M.Y., Williams, F., et al. (2017) Whipple’s Disease. Journal of the Neurological Sciences, 377, 197-206. https://doi.org/10.1016/j.jns.2017.01.048
|
[4]
|
Dolmans, R.A., Boel, C.H., Lacle, M.M., et al. (2017) Clinical Manifestations, Treatment, and Diagnosis of Tropheryma whipplei Infections. Clinical Microbiology Reviews, 30, 529-555. https://doi.org/10.1128/CMR.00033-16
|
[5]
|
Biagi, F., Balduzzi, D., Delvino, P., et al. (2015) Prevalence of Whipple’s Disease in North-Western Italy. European Journal of Clinical Microbiology & Infectious Diseases, 34, 1347-1348. https://doi.org/10.1007/s10096-015-2357-2
|
[6]
|
Scheurwater, M.A., Verduin, C.M. and Van Dantzig, J.M. (2019) Whipple’s Endocarditis: A Case Report of a Blood Culture-Negative Endocarditis. European Heart Journal Case Reports, 3, 1-6. https://doi.org/10.1093/ehjcr/ytz222
|
[7]
|
Obst, W., Von Arnim, U. and Malfertheiner, P. (2014) Whipple’s Disease. Visceral Medicine, 30, 167-172. https://doi.org/10.1159/000363781
|
[8]
|
Fenollar, F., Mediannikov, O., Socolovschi, C., et al. (2010) Tropheryma whipplei Bacteremia during Fever in Rural West Africa. Clinical Infectious Diseases, 51, 515-521. https://doi.org/10.1086/655677
|
[9]
|
Wiech, T., Reinhard, L., Wulf, S., et al. (2022) Bacterial Infection Possibly Causing Autoimmunity: Tropheryma whipplei and Membranous Nephropathy. Lancet, 400, 1882-1883. https://doi.org/10.1016/S0140-6736(22)02039-6
|
[10]
|
Du, Z.M. and Chen, P. (2023) Co-Infection of Chlamydia psittaci and Tropheryma whipplei: A Case Report. World Journal of Clinical Cases, 11, 7144-7149. https://doi.org/10.12998/wjcc.v11.i29.7144
|
[11]
|
Puéchal, X. (2013) Whipple’s Disease. Annals of the Rheumatic Diseases, 72, 797-803. https://doi.org/10.1136/annrheumdis-2012-202684
|
[12]
|
Schneider, T., Moos, V., Loddenkemper, C., et al. (2008) Whipple’s Disease: New Aspects of Pathogenesis and Treatment. The Lancet Infectious Diseases, 8, 179-190. https://doi.org/10.1016/S1473-3099(08)70042-2
|
[13]
|
Edouard, S., Fenollar, F. and Raoult, D. (2012) The Rise of Tropheryma whipplei: A 12-Year Retrospective Study of PCR Diagnoses in Our Reference Center. Journal of Clinical Microbiology, 50, 3917-3920. https://doi.org/10.1128/JCM.01517-12
|
[14]
|
Marth, T. (2009) New Insights into Whipple’s Disease—A Rare Intestinal Inflammatory Disorder. Digestive Diseases, 27, 494-501. https://doi.org/10.1159/000233288
|
[15]
|
Baloira, A., Núñez, M., Tumbeiro, M., et al. (2014) Pulmonary Hypertension Associated with Whipple Disease. European Respiratory Review, 23, 533-536. https://doi.org/10.1183/09059180.00005714
|
[16]
|
Touitou, V., Fenollar, F., Cassoux, N., et al. (2012) Ocular Whipple’s Disease: Therapeutic Strategy and Long-Term Follow-Up. Ophthalmology, 119, 1465-1469. https://doi.org/10.1016/j.ophtha.2012.01.024
|
[17]
|
Meunier, M., Puechal, X., Hoppé, E., et al. (2013) Rheumatic and Musculoskeletal Features of Whipple Disease: A Report of 29 Cases. The Journal of Rheumatology, 40, 2061-2066. https://doi.org/10.3899/jrheum.130328
|
[18]
|
Shao, J., Hassouna, A., Wang, Y., et al. (2022) Next-Generation Sequencing as an Advanced Supplementary Tool for the Diagnosis of Pathogens in Lower Respiratory Tract Infections: An Observational Trial in Xi’an, China. Biomedical Reports, 16, Article No. 14. https://doi.org/10.3892/br.2021.1497
|
[19]
|
Feurle, G.E., Junga, N.S. and Marth, T. (2010) Efficacy of Ceftriaxone or Meropenem as Initial Therapies in Whipple’s Disease. Gastroenterology, 138, 478-486. https://doi.org/10.1053/j.gastro.2009.10.041
|
[20]
|
Lagier, J.C., Fenollar, F., Lepidi, H., et al. (2014) Treatment of Classic Whipple’s Disease: From in Vitro Results to Clinical Outcome. The Journal of Antimicrobial Chemotherapy, 69, 219-227. https://doi.org/10.1093/jac/dkt310
|
[21]
|
Lagier, J.C., Fenollar, F. and Raoult, D. (2014) [Whipple’s Disease and Tropheryma whipplei Infections in Internal Medicine. When to Think about It? How to Treat?]. La Revue De Medecine Interne, 35, 801-807. https://doi.org/10.1016/j.revmed.2014.04.016
|
[22]
|
Feurle, G.E., Moos, V., Bläker, H., et al. (2013) Intravenous Ceftriaxone, Followed by 12 or Three Months of Oral Treatment with Trimethoprim-Sulfamethoxazole in Whipple’s Disease. The Journal of Infection, 66, 263-270. https://doi.org/10.1016/j.jinf.2012.12.004
|
[23]
|
Audoly, G., Fenollar, F., Lagier, J.C., et al. (2016) Deglycosylation of Tropheryma whipplei Biofilm and Discrepancies between Diagnostic Results during Whipple’s Disease Progression. Scientific Reports, 6, Article No. 23883. https://doi.org/10.1038/srep23883
|